Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 2362-2365, May 1, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dashwood, R. H.
Right arrow Articles by Bailey, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dashwood, R. H.
Right arrow Articles by Bailey, G. S.

Promotion of Aflatoxin B1 Carcinogenesis by the Natural Tumor Modulator Indole-3-carbinol: Influence of Dose, Duration, and Intermittent Exposure on Indole-3-carbinol Promotional Potency1

Roderick H. Dashwood2, Arthur T. Fong, David E. Williams, Jerry D. Hendricks and George S. Bailey

Department of Environmental Biochemistry, University of Hawaii, Honolulu, Hawaii 96822 [R. H. D.], and Department of Food Science and Technology, Oregon State University, Corvallis, Oregon 97331 [A. T. F., D. E. W., J. D. H., G. S. B.]

Indole-3-carbinol (I3C), a secondary metabolite from cruciferous vegetables, inhibits aflatoxin B1 (AFB1) hepatocarcinogenesis in trout (Bailey et al., J. Natl. Cancer Inst., 78: 931–934, 1987) and rats (Selivonchick et al., unpublished results) when given prior to and with carcinogen but promotes carcinogenesis in both species when given continuously following AFB1 initiation. Since human I3C intake may not be continuous, and the promotional stimulation may be reversible, we have assessed I3C promotion using delayed and discontinuous exposure protocols. Following initiation with AFB1, I3C was fed to trout for varying periods of time, with varying lengths of delay after initiation and continuous or intermittent patterns of I3C treatment. Promotional enhancement of tumor incidence by I3C was found to be significant when I3C treatment was delayed for several weeks or months after the initial AFB1 challenge. Promotion also was found to increase with length of exposure to I3C treatment and to be decreased but still evident when I3C was given in alternating months or weeks, or twice per week only. These results do not support the idea that promotional stimulation in hepatocarcinogenesis is a reversible phenomenon.

To quantify I3C promotional potency in terms of its dietary concentration, a series of AFB1 tumor dose-response curves was established, each with a different level of I3C fed continuously following AFB1 initiation. The resultant tumor dose-response curves, plotted as logit percentage of incidence versus log AFB1 dose, were displaced parallel toward lower AFB1 50% tumor take (TD50) values with increasing I3C concentration. The level of I3C that halves the AFB1 dose for 50% tumor incidence was calculated to be approximately 1000 ppm I3C, fed continuously, with no substantial threshold for promotion. By comparison, I3C, when fed before and with AFB1, shows a 50% inhibitory value (I3C concentration that doubles the dose of AFB1 for 50% tumor incidence) in trout of 1400 ppm I3C [Dashwood et al., Carcinogenesis (Lond.), 10: 175–181, 1989]. Thus the potential for I3C as a dietary additive to promote prior hepatic initiation events when fed continuously is approximately as great as its potential to inhibit concurrent AFB1 initiation.

1 This work was supported by USPHS Grants CA34742, EH03850, and EH00210. This is Technical Paper 9530 of the Oregon Agricultural Experiment Station.

2 To whom requests for reprints should be addressed, at Department of Environmental Biochemistry, University of Hawaii at Manoa, Henke Hall 329, 1800 East-West Road, Honolulu, HI 96822.

Received 10/15/90. Accepted 2/15/91.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
S. C. Tilton, J. D. Hendricks, G. A. Orner, C. B. Pereira, G. S. Bailey, and D. E. Williams
Gene expression analysis during tumor enhancement by the dietary phytochemical, 3,3'-diindolylmethane, in rainbow trout
Carcinogenesis, July 1, 2007; 28(7): 1589 - 1598.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
E. P. Gallagher
Using Salmonid Microarrays to Understand the Dietary Modulation of Carcinogenesis in Rainbow Trout
Toxicol. Sci., March 1, 2006; 90(1): 1 - 4.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. H. Conney
Enzyme Induction and Dietary Chemicals as Approaches to Cancer Chemoprevention: The Seventh DeWitt S. Goodman Lecture
Cancer Res., November 1, 2003; 63(21): 7005 - 7031.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
D. A. Leibelt, O. R. Hedstrom, K. A. Fischer, C. B. Pereira, and D. E. Williams
Evaluation of Chronic Dietary Exposure to Indole-3-Carbinol and Absorption-Enhanced 3,3'-Diindolylmethane in Sprague-Dawley Rats
Toxicol. Sci., July 1, 2003; 74(1): 10 - 21.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
D. E. Williams, G. S. Bailey, A. Reddy, J. D. Hendricks, A. Oganesian, G. A. Orner, C. B. Pereira, and J. A. Swenberg
The Rainbow Trout (Oncorhynchus mykiss) Tumor Model: Recent Applications in Low-Dose Exposures to Tumor Initiators and Promoters
Toxicol Pathol, January 1, 2003; 31(1_suppl): 58 - 61.
[Abstract] [PDF]


Home page
CarcinogenesisHome page
S. Herrmann, M. Seidelin, H. C. Bisgaard, and O. Vang
Indolo[3,2-b]carbazole inhibits gap junctional intercellular communication in rat primary hepatocytes and acts as a potential tumor promoter
Carcinogenesis, November 1, 2002; 23(11): 1861 - 1868.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. Stoner, B. Casto, S. Ralston, B. Roebuck, C. Pereira, and G. Bailey
Development of a multi-organ rat model for evaluating chemopreventive agents: efficacy of indole-3-carbinol
Carcinogenesis, October 1, 2002; 23(10): 1769 - 1770.
[Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
H. L. BRADLOW and D. W. SEPKOVIC
Diet and Breast Cancer
Ann. N.Y. Acad. Sci., June 1, 2002; 963(1): 247 - 267.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. Stoner, B. Casto, S. Ralston, B. Roebuck, C. Pereira, and G. Bailey
Development of a multi-organ rat model for evaluating chemopreventive agents: efficacy of indole-3-carbinol
Carcinogenesis, February 1, 2002; 23(2): 265 - 272.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
S. A. Larsen-Su and D. E. Williams
Transplacental Exposure to Indole-3-carbinol Induces Sex-Specific Expression of CYP1A1 and CYP1B1 in the Liver of Fischer 344 Neonatal Rats
Toxicol. Sci., December 1, 2001; 64(2): 162 - 168.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.